Real-time context
Follow the latest analyst actions, insider and institutional activity, earnings, dividends, price moves, and company filings.
Rating Change Truist Securities analysts reiterated a Buy rating on Crown Holdings, Inc. (NYSE:CCK) on July 22, 2026. Market Context Crown Holdings, Inc.
Read moreRating Change Benchmark analysts downgraded Penske Automotive Group, Inc. (NYSE:PAG) from Buy to Hold on July 22, 2026. Market Context Penske Automotive Group, Inc.
Read moreRating Change Keefe, Bruyette & Woods analysts reiterated a Market Perform rating on AGNC Investment Corp. 8.75% Series H Fixed-Rate Cumulative Redeemable Preferred Stock…
Read moreRating Change JP Morgan analysts reiterated a Neutral rating on AGNC Investment Corp. 8.75% Series H Fixed-Rate Cumulative Redeemable Preferred Stock (NASDAQ:AGNCZ) on July 22,…
Read moreRating Change B of A Securities analysts downgraded Rollins, Inc. (NYSE:ROL) from Buy to Underperform on July 23, 2026. Market Context Rollins, Inc.
Read moreRating Change Evercore ISI Group analysts initiated coverage on Tenax Therapeutics, Inc. (NASDAQ:TENX) with a Outperform rating on July 22, 2026. Market Context Tenax…
Read moreRating Change TD Cowen analysts reiterated a Hold rating on 7.125% Fixed-Rate Reset Subordinated Debentures due 2052 (NYSE:RZC) on July 22, 2026. Market Context 7.125% Fixed-Rate…
Read moreRating Change Citigroup analysts reiterated a Neutral rating on DiamondRock Hospitality Company (NYSE:DRH) on July 22, 2026. Market Context DiamondRock Hospitality Company…
Read moreRating Change Canaccord Genuity analysts reiterated a Buy rating on Celldex Therapeutics, Inc. (NASDAQ:CLDX) on July 22, 2026. Market Context Celldex Therapeutics, Inc.
Read moreRating Change Cantor Fitzgerald analysts reiterated a Overweight rating on Celldex Therapeutics, Inc. (NASDAQ:CLDX) on July 22, 2026. Market Context Celldex Therapeutics, Inc.
Read moreRating Change Wells Fargo analysts reiterated a Overweight rating on Celldex Therapeutics, Inc. (NASDAQ:CLDX) on July 22, 2026. Market Context Celldex Therapeutics, Inc.
Read moreRating Change Morgan Stanley analysts reiterated a Overweight rating on Celldex Therapeutics, Inc. (NASDAQ:CLDX) on July 22, 2026. Market Context Celldex Therapeutics, Inc.
Read moreRating Change Evercore ISI Group analysts reiterated a Outperform rating on Teekay Tankers Ltd. (NYSE:TNK) on July 22, 2026. Market Context Teekay Tankers Ltd.
Read moreRating Change Stephens & Co. analysts reiterated a Overweight rating on Hancock Whitney Corporation - 6 (NASDAQ:HWCPZ) on July 22, 2026. Market Context Hancock Whitney Corporation…
Read moreRating Change Benchmark analysts reiterated a Buy rating on Hancock Whitney Corporation - 6 (NASDAQ:HWCPZ) on July 22, 2026. Market Context Hancock Whitney Corporation - 6…
Read moreRating Change Keefe, Bruyette & Woods analysts reiterated a Market Perform rating on Hancock Whitney Corporation - 6 (NASDAQ:HWCPZ) on July 22, 2026. Market Context Hancock…
Read moreRating Change Baird analysts reiterated a Neutral rating on Sabra Health Care REIT, Inc. (NASDAQ:SBRA) on July 22, 2026. Market Context Sabra Health Care REIT, Inc.
Read moreRating Change Truist Securities analysts reiterated a Buy rating on Sabra Health Care REIT, Inc. (NASDAQ:SBRA) on July 22, 2026. Market Context Sabra Health Care REIT, Inc.
Read moreRating Change Citizens analysts reiterated a Market Outperform rating on Sabra Health Care REIT, Inc. (NASDAQ:SBRA) on July 22, 2026. Market Context Sabra Health Care REIT, Inc.
Read moreRating Change Stifel analysts upgraded DigitalOcean Holdings, Inc. (NYSE:DOCN) from Hold to Buy on July 22, 2026. Market Context DigitalOcean Holdings, Inc.
Read more
